| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.05. | Gilead teams up with WHO again to eliminate parasitic tropical disease | ||
| 21.05. | Eli Lilly maintains M&A streak with $202m Engage Bio buyout | ||
| 21.05. | FUJIFILM opens new iPSC facility in Madison, US | ||
| 21.05. | BMS and Anthropic collaborate for Claude implementation | ||
| 20.05. | Investment giants join forces to form largest healthcare firm on the globe | ||
| 20.05. | Clinical Trials Day 2026: 'Research Rising' theme reflected in Q1 study growth | ||
| 20.05. | Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict | ||
| 20.05. | QIAGEN and NVIDIA partner on AI drug discovery | ||
| 20.05. | SERB signs agreement to acquire Idefirix rights for $133.6m | ||
| 19.05. | UK government bolsters antiviral supply for hantavirus | ||
| 19.05. | VERTANICAL's VER-01 gains FDA breakthrough status for low back pain | ||
| 19.05. | Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates | ||
| 18.05. | Vaccine void means current Ebola outbreak declared international emergency | ||
| 18.05. | Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup | ||
| 18.05. | Japan's MHLW approves Boehringer's Jascayd for IPF and PPF | ||
| 18.05. | FDA approves Enhertu for two HER2-positive early breast cancer indications | ||
| 15.05. | Nonprofits join forces to debut marketplace for shelved CGTs | ||
| 15.05. | Arna Pharma and Slate Run complete JV for new US company | ||
| 15.05. | Biopharma industry endorses Pazdur for FDA commissioner role | ||
| 15.05. | Kyowa Kirin secures FDA approval for Crysvita dosing update | ||
| 14.05. | UK health secretary Wes Streeting resigns | ||
| 14.05. | Coya Therapeutics secures FDA fast track status for COYA 302 | ||
| 14.05. | Regulatory round-up: A month of key FDA approvals for cancer drugs | ||
| 14.05. | Imfinzi set to become first immunotherapy for stomach cancer patients on NHS | ||
| 14.05. | Zydus to acquire Assertio in $166m deal |